US antitrust regulators clear Mallinckrodt’s buyout of Questcor
MLex Summary: Specialty drugmaker Mallinckrodt said US antitrust regulators cleared the company’s proposed acquisition of Questcor Pharmaceuticals on May 9. The deal remains subject to other closing conditions, including approval by...To view the full article, register now.
Already a subscriber? Click here to view full article